Phase II trial of topotecan, cisplatin, and bevacizumab for recurrent or persistent cervical cancer.
Israel Zighelboim
Research Funding - Genentech; GlaxoSmithKline
Jason D. Wright
Research Funding - Genentech
Feng Gao
No relevant relationships to disclose
Ashley Stephens Case
No relevant relationships to disclose
L. Stewart Massad
No relevant relationships to disclose
David Gardner Mutch
Research Funding - Genentech; Lilly
Expert Testimony - Coleman v Roth*; Cornellius v Jacobs*
Matthew A. Powell
Honoraria - Genentech; GlaxoSmithKline
Research Funding - Genentech; GlaxoSmithKline
Premal H. Thaker
No relevant relationships to disclose
Eric Lawernce Eisenhauer
No relevant relationships to disclose
David E. Cohn
No relevant relationships to disclose
Fidel A. Valea
No relevant relationships to disclose
Angeles Alvarez Secord
Research Funding - GlaxoSmithKline
Lynne T. Lippmann
No relevant relationships to disclose
Janet Sue Rader
No relevant relationships to disclose